Corient Private Wealth LLC trimmed its holdings in shares of Nutanix, Inc. (NASDAQ:NTNX – Free Report) by 17.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,538 shares of the technology company’s stock after selling 1,367 shares during the quarter. Corient Private Wealth LLC’s holdings in Nutanix were worth $400,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC boosted its stake in shares of Nutanix by 0.5% during the third quarter. Geode Capital Management LLC now owns 4,147,126 shares of the technology company’s stock valued at $245,968,000 after purchasing an additional 22,091 shares during the period. Jacobs Levy Equity Management Inc. raised its position in shares of Nutanix by 15.3% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 2,816,647 shares of the technology company’s stock worth $166,886,000 after acquiring an additional 374,328 shares in the last quarter. Two Sigma Advisers LP lifted its position in Nutanix by 32.8% during the third quarter. Two Sigma Advisers LP now owns 2,814,002 shares of the technology company’s stock valued at $166,730,000 after buying an additional 695,567 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Nutanix by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,442,805 shares of the technology company’s stock worth $88,271,000 after purchasing an additional 33,980 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Nutanix during the 4th quarter valued at approximately $86,824,000. Institutional investors own 85.25% of the company’s stock.
Insider Activity
In other news, Director Groen Max Pieter De sold 5,500,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $74.51, for a total value of $409,805,000.00. Following the completion of the sale, the director now directly owns 11,354,032 shares in the company, valued at $845,988,924.32. This represents a 32.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Rajiv Ramaswami sold 7,740 shares of the company’s stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $75.00, for a total transaction of $580,500.00. Following the completion of the sale, the chief executive officer now directly owns 558,366 shares of the company’s stock, valued at $41,877,450. This represents a 1.37 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,610,886 shares of company stock worth $417,646,356 over the last three months. 6.80% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on NTNX
Nutanix Stock Down 1.3 %
Shares of NTNX opened at $71.02 on Friday. The stock’s 50-day moving average price is $70.38 and its 200-day moving average price is $66.38. Nutanix, Inc. has a 52 week low of $43.35 and a 52 week high of $79.99. The company has a market capitalization of $18.94 billion, a price-to-earnings ratio of -202.91, a PEG ratio of 11.80 and a beta of 1.04.
Nutanix Company Profile
Nutanix, Inc engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure.
Further Reading
- Five stocks we like better than Nutanix
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Healthcare Dividend Stocks to Buy
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Using the MarketBeat Stock Split Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding NTNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutanix, Inc. (NASDAQ:NTNX – Free Report).
Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.